gvtcx

SARS-CoV-2 (2019-nCoV) Spike RBD(N501Y)-His Recombinant Protein for Covid 19 activity (new variant strain of Covid).

Public Health England Published 22 Jan 2021 Contracts Finder

key details

Value£11,150
Statuscomplete
Category (CPV) 33140000 +1 more
Deadline29 Dec 2020
Contract start30 Dec 2020
Contract end31 Mar 2021
Proceduredirect
SME suitableYes
OCIDocds-b5fd17-025fddec-7da3-49a4-9c17-9dd6c638f3a8

Award

SupplierValueDateStatus
Sino Biological £11,150 30 Dec 2020 active

description

The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020.

Public Health England (PHE) discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004).

This requirement is in response to the recent COVID -19 outbreak. PHE has awarded a contract to Sino Biological for the purchase of SARS-CoV-2 (2019-nCoV) Spike RBD(N501Y)-His Recombinant Protein for Covid 19 activity (new variant strain of Covid) due to extreme urgency under current public procurement regulations using regulation 32(2)(c).

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
22 Jan 2021 Award (award) · 67046d9d-7cdb-435d-930c-dd36f88bbbc9-407702

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.